María Teresa Bourlon, MD, MS, FASCO, previews practice-changing research at ASCO GU 2026

In this preview of research expected at the 2026 ASCO Genitourinary Cancers Symposium, medical oncologist María Teresa Bourlon, MD, MS, FASCO, outlined major clinical advances anticipated across prostate, urothelial, kidney, and testicular cancers. Speaking from her practice at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, she emphasized that the meeting will focus heavily on survival outcomes, biomarker-guided therapy, and emerging treatment mechanisms.